BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 7489347)

  • 1. Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea.
    Park BC; Han BH; Ahn SY; Lee SW; Lee DH; Lee YN; Seo JH; Kim KW
    J Viral Hepat; 1995; 2(4):195-202. PubMed ID: 7489347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
    Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
    J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of serum HBV DNA and anti-HCV antibody in HBsAg seronegative patients with hepatocellular carcinoma in Japan.
    Tokeshi S; Sata M; Tanikawa K
    Kansenshogaku Zasshi; 1996 Feb; 70(2):103-7. PubMed ID: 8851381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of HCV-RNA and HBV-DNA in the serum of HBsAg negative patients with hepatocellular carcinoma.
    Enríquez J; Fuchs K; Martínez Cerezo FJ; Seminago R; Madoz P; Torras J; Roggendorf M
    Eur J Epidemiol; 1994 Apr; 10(2):189-94. PubMed ID: 7813697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of HBV DNA in HBsAg-negative, anti-HCV-positive hepatocellular carcinoma: existence of HBV DNA possibly as nonintegrated form with analysis by Alu-HBV DNA PCR and conventional HBV PCR.
    Kawai S; Yokosuka O; Imazeki F; Maru Y; Saisho H
    J Med Virol; 2001 Aug; 64(4):410-8. PubMed ID: 11468724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY; Ahn MS; Chang HJ
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
    Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
    Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.
    Shiratori Y; Shiina S; Imamura M; Kato N; Kanai F; Okudaira T; Teratani T; Tohgo G; Toda N; Ohashi M
    Hepatology; 1995 Oct; 22(4 Pt 1):1027-33. PubMed ID: 7557847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.
    Di Bisceglie AM; Simpson LH; Lotze MT; Hoofnagle JH
    J Clin Gastroenterol; 1994 Oct; 19(3):222-6. PubMed ID: 7528758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.
    Weinig M; Hakim JG; Gudza I; Tobaiwa O
    Trans R Soc Trop Med Hyg; 1997; 91(5):570-2. PubMed ID: 9463670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.
    Farinati F; Fagiuoli S; De Maria N; Chiaramonte M; Aneloni V; Ongaro S; Salvagnini M; Naccarato R
    J Hepatol; 1992 Mar; 14(2-3):183-7. PubMed ID: 1380021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interest of the detection of hepatitis C virus RNA in patients with alcoholic liver disease. Comparison with the HBV status.
    Zarski JP; Thelu MA; Moulin C; Rachail M; Seigneurin JM
    J Hepatol; 1993 Jan; 17(1):10-4. PubMed ID: 7680361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.